Extracellular vesicle infusion for prediabetes
Part of Hormones & metabolism clinical trials.
This trial tests an infusion of tiny particles from cells (called extracellular vesicles) given to people with early signs of aging, like slightly high blood sugar after meals. The goal is to see if this treatment is safe and can help improve blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 35 and 65 years old
- Your body mass index (BMI) is between 20 and 30
- You have 'prediabetes' – your after-meal blood sugar is slightly high (7.8–11.0 mmol/L) but not full diabetes
- You are not allergic to any components used in the cell culture
- You have not taken drugs that affect blood sugar (like steroids or certain antidepressants) in the last month
- You are not pregnant, breastfeeding, or planning pregnancy in the next 2 years, and you are willing to use effective contraception
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study looks at whether a treatment can help reverse problems in blood vessels caused by high glucose (sugar) and blood fat signals. It may be a fit if you are generally healthy, have normal insulin and sugar levels, and have a stable weight.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.
This study tests an experimental stem cell treatment (DT2-SCT) to see if it can improve blood sugar control in people with type 2 diabetes who need insulin. It is a double-blind study, so neither you nor the study team will know if you get the real treatment or a placebo.
This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.
Hear when a new Impaired Glucose Tolerance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.